Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study.

Autor: Iseda N; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Itoh S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. itoh.shinji.453@m.kyushu-u.ac.jp., Toshima T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Yoshiya S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Bekki Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Tsutsui Y; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Toshida K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Inokuchi S; Department of Surgery, Oita Prefectural Hospital, Oita, 870-8511, Japan., Utsunomiya T; Department of Surgery, Oita Prefectural Hospital, Oita, 870-8511, Japan., Tomino T; Department of Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan., Sugimachi K; Department of Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan., Morita K; Department of Surgery, Fukuoka City Hospital, Fukuoka, 812-0046, Japan., Ninomiya M; Department of Surgery, Fukuoka City Hospital, Fukuoka, 812-0046, Japan., Harada N; Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, 810-0001, Japan., Minagawa R; Department of Surgery, Japanese Red Cross Matsuyama Hospital, Matsuyama, 790-8524, Japan., Yoshizumi T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Jazyk: angličtina
Zdroj: Surgery today [Surg Today] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
DOI: 10.1007/s00595-024-02930-x
Abstrakt: Background and Purpose: In recent years, new systemic therapies have been developed for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the prognosis of patients with unresectable HCC treated with R0 hepatectomy after systemic therapy.
Methods: Data from 27 patients who underwent hepatectomy for HCC after systemic therapy at six facilities were analyzed retrospectively. Cancer-specific survival (CSS) and recurrence-free survival (RFS) after hepatectomy were investigated using Kaplan-Meier curves. We examined the prognostic value of the oncological criteria of resectability for HCC reported by the Japanese Expert Consensus 2023.
Results: R0 resection was performed in 24 of the 27 patients. Using the Response Evaluation Criteria in Solid Tumors, 0 patient had a complete response, 16 had a partial response, 6 had stable disease, and 2 had progressive disease. Median CSS was not evaluated, but the median RFS was 17.8 months. Patients with resectable and borderline resectable (BR) 1 cancers had a better prognosis than those with BR2 cancers. The group whose oncological criteria were improved by systemic therapy had a lower recurrence rate than the group whose oncological criteria were maintained, but no difference was observed in CSS.
Conclusions: The findings of this study suggest that hepatectomy after systemic therapy may improve the prognosis of HCC patients.
(© 2024. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.)
Databáze: MEDLINE
Externí odkaz: